Medicine and Dentistry
Neoplasm
100%
Surgery
97%
Hepatocellular Carcinoma
68%
Metastatic Carcinoma
63%
Disease
54%
Malignant Neoplasm
51%
Breast Cancer
50%
Surgeon
41%
Overall Survival
38%
Pancreas Adenocarcinoma
35%
Pancreas Cancer
34%
Hepatectomy
34%
Cancer
31%
Recurrent Disease
30%
Pancreaticoduodenectomy
26%
Colorectal Liver Metastasis
23%
Liver Metastasis
22%
Liver Cirrhosis
16%
Odds Ratio
16%
Adrenal Cortex Carcinoma
16%
Colorectal Cancer
16%
Stomach Cancer
15%
Oncologist
15%
Hazard Ratio
15%
Retroperitoneal Lymph Node Dissection
15%
Oncology
15%
Clinical Trial
14%
Symptomatic Treatment
13%
Vasculotropin
13%
Catheter Ablation
13%
Cholangiocarcinoma
12%
Adenocarcinoma
12%
Osteonectin
12%
Lymph Node
12%
Liver Tumor
12%
Tumor Progression
11%
Radiation Therapy
10%
Sentinel Lymph Node
10%
Radiofrequency Ablation
10%
Primary Tumor
10%
General Surgery
10%
Adjuvant Therapy
10%
Liver Cancer
10%
Cancer Cell
9%
Neoadjuvant Chemotherapy
9%
Magnetic Resonance Imaging
9%
Axillary Lymph Node
9%
Tumor Cell
9%
Neuroendocrine Tumor
8%
Stomach Adenocarcinoma
8%
Liver Injury
8%
Survival Rate
8%
Meta-Analysis
8%
Lymph Duct
8%
Adjuvant Chemotherapy
7%
Cancer Staging
7%
Disease Free Survival
7%
Long Term Survival
7%
Cytoreductive Surgery
7%
Neoadjuvant Therapy
7%
Injury
7%
Multivariate Analysis
7%
Colon Cancer
7%
Computer Assisted Tomography
7%
Extracellular Matrix
7%
Pathologist
7%
Health Care Cost
6%
Operating Room
6%
Chemoradiotherapy
6%
Rectum Cancer
6%
Logistic Regression Analysis
6%
Systemic Therapy
6%
Carcinoma
6%
Surgical Margin
6%
Surgical Technique
6%
Distal Pancreatectomy
6%
Preoperative Chemotherapy
6%
Stroma
6%
Robot-Assisted Surgery
6%
Peroperative Echography
6%
Biopsy
6%
Liver Surgery
6%
Pancreas Islet Cell Tumor
6%
Liver Transplantation
6%
Recurrence Free Survival
6%
Quadrantectomy
5%
Awareness
5%
Proportional Hazards Model
5%
Diagnosis
5%
Distant Metastasis
5%
Lymph Node Metastasis
5%
Macrophage
5%
Systematic Review
5%
Nodular Melanoma
5%
Sentinel Node
5%
Bleeding
5%
In Vitro
5%
Cancer Therapy
5%
Body Mass Index
5%
Pancreas Tumor
5%
Keyphrases
Hepatocellular Carcinoma
29%
Tumor
22%
Resection
18%
Overall Survival
16%
Pancreatic Cancer
14%
Peritoneal Surface Malignancy
13%
Colorectal Liver Metastases
13%
Chicago
13%
United States
12%
Pancreatic Ductal Adenocarcinoma
12%
Adrenocortical Carcinoma
9%
Confidence Interval
9%
Cirrhosis
8%
Pancreaticoduodenectomy
8%
Liver
8%
Colorectal Cancer
7%
Medical Oncologist
7%
Vascular Endothelial Growth Factor
7%
Hepatic Resection
7%
Pancreatic Adenocarcinoma
7%
Hazard Ratio
7%
Surgical Resection
6%
Radiologists
6%
Surgical Oncologist
6%
Pathologist
6%
Enhanced Awareness
6%
Peritoneal Surface Disease
6%
Pharmacist
6%
Palliative Care Physicians
6%
Appropriate Management
6%
Hepatocellular Carcinoma Surveillance
6%
Gastric Cancer
5%
Early Hepatocellular Carcinoma
5%
NCCN Guidelines
5%
Tumor Microenvironment
5%
Metastasis
5%
Discoidin Domain Receptor 1 (DDR1)
5%
Adjuvant Therapy
5%
Vascular Endothelial Growth Factor Receptor 2 (VEGFR2)
5%